9960 — Kindstar Globalgene Technology Income Statement
0.000.00%
- HK$1.47bn
- -HK$474.39m
- CNY967.26m
- 26
- 62
- 67
- 51
Annual income statement for Kindstar Globalgene Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 833 | 891 | 931 | 1,387 | 967 |
Cost of Revenue | |||||
Gross Profit | 450 | 459 | 484 | 599 | 450 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 998 | 1,851 | 2,383 | 1,301 | 916 |
Operating Profit | -165 | -960 | -1,452 | 85.8 | 51.4 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -169 | -962 | -1,454 | 83.3 | 43.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -170 | -970 | -1,454 | 77.5 | 36.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -170 | -974 | -1,454 | 75.5 | 41.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -170 | -974 | -1,454 | 75.5 | 41.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.188 | -1.07 | -2.92 | 0.125 | 0.022 |
Dividends per Share |